I spoke with one of the directors about a month back they felt China sales was more relevant than FDA approval for a share rerating as the US military have allready effectively stamped this as the bees knees and FDA rating then becomes just a formality.
have a look at Tissue therapies ASX listed as TIS and a similar biotech.
I spoke with one of the directors about a month back they felt...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.67 |
Change
0.040(1.52%) |
Mkt cap ! $188.0M | |||
| Open | High | Low | Value | Volume |
| $2.67 | $2.70 | $2.64 | $404.6K | 152.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5532 | $2.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.68 | 15319 | 3 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |